216 related articles for article (PubMed ID: 7308514)
1. Bromocriptine reduction of prolactinoma size.
Corenblum B; Hanley DA
Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
Niwa J; Sato O; Tanabe S
Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
4. Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.
Woodhouse NJ; Khouqueer F; Sieck JO
Horm Res; 1981; 14(3):141-7. PubMed ID: 7286886
[TBL] [Abstract][Full Text] [Related]
5. Effective management of a suprasellar extending prolactinoma during pregnancy.
Pittini L; Minisci N; Negri P
Clin Exp Obstet Gynecol; 1987; 14(3-4):152-4. PubMed ID: 3454722
[TBL] [Abstract][Full Text] [Related]
6. Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine.
Ayers JW
Fertil Steril; 1983 Dec; 40(6):846-8. PubMed ID: 6653805
[No Abstract] [Full Text] [Related]
7. Cerebrospinal fluid rhinorrhea during treatment with bromocriptine for prolactinoma.
Kok JG; Bartelink AK; Schulte BP; Smals A; Pieters G; Meyer E; Merx H
Neurology; 1985 Aug; 35(8):1193-5. PubMed ID: 4022353
[TBL] [Abstract][Full Text] [Related]
8. Assessment by computed tomography of the response of pituitary macroadenomas to bromocriptine.
Chakera TM; Khangure MS; Pullen P
Clin Radiol; 1985 May; 36(3):223-6. PubMed ID: 4064503
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
[TBL] [Abstract][Full Text] [Related]
10. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
Breidahl HD; Topliss DJ; Pike JW
Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
[TBL] [Abstract][Full Text] [Related]
11. Rapid decompression of anterior intracranial visual pathways with bromocriptine.
Grimson BS; Bowman ZL
Arch Ophthalmol; 1983 Apr; 101(4):604-6. PubMed ID: 6838419
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term treatment with bromocriptine on pituitary prolactinoma in a male.
Ayalon D; Eckstein N; Homonnai ZT; Paz GF; Eshel A; Reider I
Int J Gynaecol Obstet; 1982 Dec; 20(6):481-5. PubMed ID: 6130996
[TBL] [Abstract][Full Text] [Related]
13. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
[TBL] [Abstract][Full Text] [Related]
14. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
[TBL] [Abstract][Full Text] [Related]
15. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
Tan SL; Jacobs HS
Int J Gynaecol Obstet; 1986 Jun; 24(3):209-15. PubMed ID: 2880760
[TBL] [Abstract][Full Text] [Related]
16. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
Canales ES; García IC; Ruíz JE; Zárate A
Fertil Steril; 1981 Oct; 36(4):524-6. PubMed ID: 7286276
[No Abstract] [Full Text] [Related]
18. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
Dalzell GW; Atkinson AB; Carson DJ; Sheridan B
Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115
[TBL] [Abstract][Full Text] [Related]
19. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
Boulanger CM; Mashchak CA; Chang RJ
Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
[TBL] [Abstract][Full Text] [Related]
20. Reduction in size of a pituitary tumor by bromocriptine therapy.
McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
[No Abstract] [Full Text] [Related]
[Next] [New Search]